《新股消息》中集車輛(01839.HK)明日起招股入場費4,080.71元
中集集團(02039.HK)分拆的中集車輛(01839.HK)於明起至7月3日招股,招股價介乎6.38-8.08元,以每手500股計,入場費4,080.71元。
是次共發行2.65億股,其大10%在港作公開發售。獨家保薦人為海通國際,股份於7月11日上市。
以中位數計,集資淨額為17.92億元,其中70%用於在美國及歐洲開設新的生產或組裝廠;10%用於研發新產品;10%用於償還銀行借款;10%用於一般營運資金。
公司引入兩名基礎投資者,山東玲瓏輪胎股份將認購3,500萬美元股份,而上汽集團將認購5,000萬美元股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.